Healthcare founders are increasingly skeptical of the traditional venture funding model and seeking alternative financial models that don't require massive capital raises.

Traditional VC playbook of seed → Series A → B → C has been ineffective for UK healthtech success despite high capital raises, exemplified by Babylon's $4.2bn valuation failure.

VC funding model traditionally used to build healthtech businesses is becoming questioned as founders increasingly explore lean, bootstrap-friendly alternatives to avoid venture capital altogether.